Introduction {#sec1-1}
============

Office blood pressure monitoring (OBPM) as is usually practiced may not provide a representative measure of an individual\'s blood pressure (BP) outside the medical setting. Out-of-office BP assessment with home blood pressure monitoring (HBPM) and ambulatory blood pressure monitoring (ABPM) have the potential for a better classification of the hypertensive status compared with OBPM. HBPM devices are endorsed for repeated measurements outside the medical environment.\[[@ref1][@ref2]\]

ABPM is currently the gold standard for the correct diagnosis of hypertension as it provides extensive information on several BP parameters other than average BP, including BP variability, morning BP surge, BP load, and nocturnal drop in BP.\[[@ref3]\] ABPM is not widely available in primary care practice and is considered most helpful, when HBPM values are borderline. HBPM is recommended as an initial step to screening out-of-office BP (1-3) leading to an ABPM, for confirmation. However, it is not well-known whether this strategy is appropriate because ABPM and HBPM may provide different and complementary information. Studies have shown that these two measures do not have a high correlation\[[@ref4]\] or a good agreement.\[[@ref5]\] The reliability of the three methods of BP measurement has been based on one or two time points following renal transplantation.\[[@ref6][@ref7]\] To assess the reliability of the three methods, prospective and longitudinal studies have been suggested. This study assess the reliability of OBPM and ABPM from the pretransplant period, 2^nd^, 4^th^ 6^th^, and 9^th^ months and all the three methods at 6^th^ month after renal transplantation.

Patients and Methods {#sec1-2}
====================

Patients receiving living-related renal transplantation from March 2007 to February 2008 at Christian Medical College, Vellore, India were prospectively followed-up with the study protocol till January 2009, after a written consent. The protocol was approved by the Clinical Investigation Ethics Committee and the Institutional Review Board.

Study subjects {#sec2-1}
--------------

Inclusion criteria included renal allograft recipients ≥18 years, treated with prednisolone, tacrolimus, and mycophenolate. The exclusion criteria included recipients \<18 years, inability to complete a 9-month follow-up, death, or allograft failure during the study period.

Study protocol {#sec2-2}
--------------

Baseline evaluation prior to and at 9^th^ month following transplantation included measurements of OBPM and ABPM and instructions for patients on the use of HBPM with a mercury sphygmomanometer. Further, at 2^nd^, 4^th^, 6^th^, and 9^th^ months follow up period. OBPM and ABPM were done. All the three methods of BP measurement were performed at the 6^th^ month.

### BP monitoring {#sec3-1}

Data from the ABPM were used as the gold standard. BP was defined as controlled when both systolic BP (SBP) and diastolic blood pressure (DBP) were within the normal range, defined by The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure (JNC 7), for all the methods used. The normal values used were: OBPM (\<140/90 mm Hg) and HBPM (\<135/85 mm Hg) and hypertension was diagnosed when DBP and/or SBP were higher than the defined ranges. Similarly, B*P* \<130/80 mm Hg with OBPM was considered "controlled" in this study.\[[@ref8]\]

### OBPM protocol {#sec3-2}

Three measurements were taken by physicians according to guidelines of the World Health Organization. BP was measured with a standard mercury sphygmomanometer, sitting, after 10 min of rest with the cuff size adjusted for the individual\'s arm circumference. Timed measurements of OBPM were taken during the initiation and termination of the ABPM on the nonfistula arm and an average of the three measurements were compared with ABPM.

### ABPM protocol {#sec3-3}

BP was recorded with an ambulatory blood pressure monitor with software (Welch Allyn ABPM 6100, 2007, New York) over 24 hrs on a regular working day starting at 9 am at half hour intervals till 9 am the next day with a record of the time they went to bed and awoke. BP profiles were obtained at 1 week prior to transplantation and at 2^nd^, 4^th^, 6^th^, and 9^th^ months after transplantation. The means of BP while awake, BP during sleep, and for 24 h BP as well as pulse rates were extracted from the data.

### HBPM protocol {#sec3-4}

A relative staying continually with the patient (usually donors, spouse, parents, or siblings) was trained and supervised by a trained nurse to measure BP at home with a mercury sphygmomanometer in the clinic for consistency and accuracy. At the 6^th^ month HBPM was done at 8 am, 12 pm, 4 pm, and 8 pm; four times on each occasion, for 7 consecutive days. The mean values of the DBP and SBP were used for comparison. OBPM and ABPM were done a week before HBPM.

Statistical methods {#sec2-3}
-------------------

Descriptive statistics such as mean, standard deviation (SD), and proportions were used for demography, clinical, laboratory characteristics, and OBPM, HBPM and ABPM registries. Student\'s *t*-test was done to compare means of BP. Linear regression was used to estimate the change in BP per month. Bootstrap simulations were done 1000 times to compare two means and also for the regression estimation of change per month, assuming a normal distribution. Bland-Altman (mean difference) plot was created over time for ABPM (2^nd^, 4^th^, and 6^th^ months post transplant) against a mean difference of OBPM-ABPM and HBPM (6^th^ month) against a mean difference of OBPM-HBPM, for both SBP and DBP. Prevalence adjusted and bias adjusted kappa was used to study agreement. All analyses were performed using a SPSS 16.0.

Results {#sec1-3}
=======

We prospectively evaluated 49 living-related renal allograft recipients, 39 males, during the period of 2006-2009 on tacrolimus, prednisolone, mycophenolate mofetil/sodium before transplantation, at 2^nd^, 4^th^, 6^th^, and 9^th^ months after transplantation. The prevalence of pretransplant hypertension was 91% and 71.4%, had posttransplant hypertension with 45% of patients on ≤2 drugs. The average estimated glomerular filtration rateable and creatinine at each follow-up during the study period were approximately 70 mL/min and 1.2 mg% \[Tables [1](#T1){ref-type="table"} and [2](#T2){ref-type="table"}\].

###### 

Patient demographics

![](IJN-24-154-g001)

###### 

Clinical demographics

![](IJN-24-154-g002)

[Table 3](#T3){ref-type="table"} presents the mean (SD) of SBP measured by awake ABPM and OBPM at the pretransplant, 2^th^, 4^th^, 6^th^, and 9^th^ months and HBPM, awake ABPM and OBPM at the 6^th^ month. The mean and 95% confidence interval (CI) of difference between these two methods and Bootstrap-based simulated mean difference and the 95% CI are also presented. At pretransplant assessment, the mean difference between the two methods was − 12.4 and 95% CI (−18.7, -6.2) implying that OBPM reading was significantly higher (*P* \< 0.05). The difference was − 1.1 (-5.0, 2.8), −3.8 (−7.4, −0.2), −1.8 (-5.2, 1.6), and − 2.0 (-5.6, 1.6) mm Hg at 2^th^, 4^th^, 6^th^, and 9^th^ months, respectively. The simulated 95% CI were similar to the 95% CI.

###### 

Mean (SD) of systolic blood pressure by awake ambulatory blood pressure monitoring, office blood pressure monitoring, and home blood pressure monitoring methods

![](IJN-24-154-g003)

Similarly for DBP, the mean (SD) and 95% CI of difference between these two methods and Bootstrap-based simulated mean difference and the 95% CI are presented in [Table 3](#T3){ref-type="table"}. At pretransplant measurement, the mean difference between the two methods was -7.4 and 95% CI (−11.6, −3.2) implying that OBPM was significantly higher (*P* \< 0.05). The difference and 95% CI was-7.3 (−10.3, −4.3), −8.7 (−11.2, −6.2), −6.8 (−9.1, −4.5) and −7.5 (−10.4, −4.5) mmHg at 2^th^, 4^th^, 6^th^, and 9^th^ months, respectively. At all time points of measurement, the difference was statistically significant with average of an 8 mm Hg over estimation consistently by the OBPM. The simulated 95% CIs were similar to the 95% CI.

ABPM and HBPM at 6^th^ month {#sec2-4}
----------------------------

The mean (SD) of SBP at 6^th^ month was 118.6 (7.3) and 121.4 (10.1) by ABPM and HBPM, respectively. The difference between these was −2.8 mm Hg with 95% CI (−6.4, 0.7). However, the bootstrap 95% CI was (−6.3, 0.5). Similarly, the mean (SD) of DBP at 6^th^ month was 72.4 (6.0) and 79.9 (4.9) mm Hg/h by ABPM and HBPM readings, respectively. The difference between these was −7.6 with 95% CI (−9.7, −5.3) and the bootstrap 95% CI was (−9.7, −5.3) mm Hg.

Mean difference plots in awake SBP of ABPM and office BP {#sec2-5}
--------------------------------------------------------

The mean difference plot of SBP for different time points is shown in [Figure 1](#F1){ref-type="fig"}. At the pretransplant phase, the scatter was evenly distributed over the range of SBP suggesting that there is an even estimation of SBP for the particular range of SBP. However, during the post transplant phase there was a systematic over estimation of SBP by OBPM at all points, with a good agreement.

![Awake systolic blood pressure in ambulatory blood pressure monitoring and office systolic blood pressure](IJN-24-154-g004){#F1}

The mean difference plot of DBP at various time points is given in [Figure 2](#F2){ref-type="fig"}. The scatter showed an evenly distributed overestimation of 8 mm Hg at all-time points.

![Awake DBP in ambulatory blood pressure monitoring and office diastolic blood pressure](IJN-24-154-g005){#F2}

The mean difference plot of SBP and DBP at 6^th^ month is given in [Figure 3](#F3){ref-type="fig"}. At 6^th^ month post transplantation, the scatters were evenly distributed showing overestimation of SBP of 2.8 mm Hg and DBP 7.6 mm Hg consistently.

![Home blood pressure monitoring and ambulatory blood pressure monitoring at 6^th^ month](IJN-24-154-g006){#F3}

The concordance rate was 69% for the diagnosis of hypertension at baseline; however, this increased to 86% at 2^nd^ month and remained above 90% subsequently. This was reflected in the kappa statistics showing similar agreement. The concordance rate for target goal of BP (\<130/80 mm Hg) showed that HBPM specificity (83%) was higher at 6 months than OBPM (50%) when compared with ABPM \[[Table 4](#T4){ref-type="table"}\].

###### 

Correlation between office blood pressure monitoring and home blood pressure monitoring with ambulatory blood pressure monitoring in the diagnosis of hypertension and maintenance of targets of blood pressure

![](IJN-24-154-g007)

On comparing the three methods of BP measurements by latent class model analysis, ABPM had the best results both for the diagnosis of elevated BP (sensitivity 6.8%; specificity 100%) and measurement of reaching the targets of BP (sensitivity 99%; specificity 99%).

Discussion {#sec1-4}
==========

The use of OBPM in the management of clinical hypertension is limited by fewer measurements and the white-coat effect.\[[@ref9]\] Currently ABPM is recommended, over the OBPM.\[[@ref9][@ref10]\] This study suggests HBPM appears to be a valid and a simple alternative to OBPM and ABPM. It has the advantages of convenience and cost savings while representing BP readings in the ambient environment. HBPM needs further validation in clinical practice.\[[@ref11]\]

The study shows that although both OBPM and HBPM presented a fair correlation with ABPM, the HBPM is superior with less error. HBPM was more specific in the assessment of the targets of therapy of BP (\<130/80 mm Hg). A recent study concluded that despite their methodological differences, there seems to be considerable similarity between morning home BP and morning ambulatory BP and thus these methods appear to be interchangeable in the assessment of hypertension.\[[@ref12]\]

This study have taken multiple measurements for HBPM, OBPM, and ABPM to produce the maximum reliability among the three methods of BP measurements as in other studies\[[@ref3][@ref4][@ref6][@ref7]\] in literature, where the measurements have been few. We have used ABPM as a "gold standard"\[[@ref13]\] for comparing with HBPM using the average daytime BP for comparison as in another report by Agena *et al.*\[[@ref6]\] With HBPM, there is no consensus regarding the frequency of readings or the days needed for observation. Studies are based on reproducibility and consistency of BP with HBPM.\[[@ref14]\]

During this study, with OBPM and HBPM most of the BP measurements obtained at the same time were similar. The Bootstrap simulations were similar to the observations from the 49 patients with normal distribution indicating the results with a sample size though small are valid.

Our transplant clinic adequately controlled BP in 91% of patients compared with 5% in the study by Paoletti *et al.*,\[[@ref13]\] and 36% at the last follow-up in Agena\'s study.\[[@ref6]\] The large difference is partly due to the variation in the definition of normotension in the setting of ABPM, 130/80 mmHg in Paoletti\'s study, and 135/85 mmHg in our patients who had a better allograft function.

The present study showed SBP with OBPM were significantly higher at all time points as compared with ABPM similar to other report.\[[@ref13]\] However in contrast to two studies\[[@ref6][@ref15]\] where the DBP measurements with OBPM did not show much variation with the awake ABPM, this study demonstrated that OBPM and HBPM overestimated BP when compared with awake ABPM. The degree of overestimation by HBPM was lower than OBPM in our study has also shown by Agena *et al.*\[[@ref6]\] The manual sphygmomanometer readings could be replaced by automated OBPM reducing errors and are similar to mean awake ABPM.\[[@ref12]\]

ABPM reflect the mean measurements of BP taking into the consideration the nocturnal dipping, the timing of antihypertensive medications without the influence of white-coat effect, unlike OBPM. No algorithm or regression equation can be determined from comparative studies, because ABPM is both underestimated and overestimated by OBPM. Overestimation may be attributable to white-coat hypertension, whereas underestimation could be explained by the fact that the studied patients take their antihypertensive medication shortly before the OBPM or because they have a high nocturnal BP.\[[@ref16]\]

The latent class model analysis showed that ABPM is the best modality for the diagnosis and assessment of the target of ≤135/85 mm Hg in hypertensive renal transplant recipients. ABPM is expensive and center limited; while HBPM is relevant, reliable, and is easier to incorporate into the home care of renal transplant patients.

Conclusion {#sec1-5}
==========

ABPM is the best modality in diagnosis and treatment of hypertension in renal transplant recipients. However, in resource-limited situations multiple measurements of HBPM would be a valid alternative, while OBPM would facilitate the diagnosis of hypertension. The care of a hypertensive renal transplant recipient should shift home with a greater patient involvement.
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